Philosys Healthcare Delays Supply Contract at Counterparty's Request... "Not Due to Production or Supply Issues"
[Asia Economy Reporter Hyunseok Yoo] Philosis Healthcare announced on the 27th that it has postponed a single sales supply contract.
This contract was initially disclosed on September 3rd and involves supplying approximately 3 billion KRW worth of COVID-19 specimen collection kits to the United States.
The original contract end date was November 30th. However, at the request of the contracting party, the supply has been postponed until January 30th of next year.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
- "Realizing How Fast Money Disappears: Should You Try Only the Essentials for 5,000 Won? [The Basics of Benefits]"
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
A Philosis Healthcare representative stated, “The extension of the supply period is due to the contracting party's request, not due to any issues with production or supply. Philosis Healthcare is prepared to supply promptly at any time. Domestic supply is proceeding smoothly, and discussions are ongoing to complete other U.S. supply orders within the deadline. We are making efforts to return to profitability in the fourth quarter.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
